Genpharmasec Reports Flat Performance and Receives 'Sell' Call from MarketsMOJO
Genpharmasec, a microcap trading company, reported a flat performance with a score of -2 in the December 2023 quarter, a decrease from 0 in the previous quarter. The company's struggles are reflected in its consistently decreasing PBT less Other Income over the last five quarters, with a low of Rs -0.11 crore in the latest quarter. MarketsMojo has given a 'Sell' call for the company's stock based on its current financial performance.
Genpharmasec, a microcap trading company, recently announced its financial results for the quarter ending December 2023. The company's performance has been reported as flat, with a score of -2, a decrease from 0 in the previous quarter. This decline in score is indicative of the company's struggles in the last three months.
One of the major factors contributing to this decline is the Profit Before Tax (PBT) less Other Income, which has been consistently decreasing over the last five quarters. In the December 2023 quarter, the PBT was reported at a low of Rs -0.11 crore, showing a downward trend. This is a concerning sign for the company's near-term financial outlook.
Based on these financial results, MarketsMOJO has given a 'Sell' call for Genpharmasec's stock. This recommendation is based on the company's current financial performance and does not take into account any future potential or external factors. As a microcap company in the trading industry, Genpharmasec will need to address its financial struggles in order to improve its overall performance and investor confidence.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
